-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US7140461093-
PerkinelmerBörse NYSE New York Stock ExchangeISIN US7140461093 WKN: 850943USDSymbol PKI
-
PerkinelmerBörse Börse FrankfurtISIN US714046AG46EURSymbol PKN
-
PerkinelmerBörse Börse BerlinISIN XS1713466578EURSymbol PKN
-
PERKINELMER INCBörse Börse StuttgartEURSymbol PKN
-
PERKINELMER INCBörse Börse DüsseldorfEURSymbol PKN
-
PERKINELMER INCBörse Quotrix System der Börse DüsseldorfEURSymbol PKN
-
PERKINELMER INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol PKN
-
PERKINELMER INCBörse Gettex System der Börse MünchenEURSymbol PKN
-
USDISIN US7140461093 WKN: 850943
-
BRLISIN US714046AH29
-
Symbol PKN
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
16.630.378.496 oder 9.082.681.823 oder 11.558.560.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
13.000 oder 11.000 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
40.26 oder 47.1
Zahlte zuletzt am 15.04.2021 eine Dividende von 0,07 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 0,18 % p. a.
beim aktuellen Kurs von 130,95 EUR +0,84%
Perkinelmer outperformed den DAX um +301 % (+6 % Dividenden) vom 30.09.2013 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 130,95 EUR +0,84%
Letzte Communitymeinungen
- Ein User war zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
smART
Ein User hat Perkinelmer abonniert.
Aktionärsstruktur der PerkinElmer, Inc
Portrait der Perkinelmer Aktie
Das Unternehmen PerkinElmer, Inc aus USA beschäftigt 12.000 Mitarbeiter und ist in den Bereichen LifeScience, Medizinische Produkte / Medizintechnik, Sonstige Technologie, Wissenschaftliche & technische Geräte, Elektrotechnologie tätig.
Die Perkinelmer Aktie hat inklusive der Dividendenausschüttungen seit dem 30.09.2013 eine Gesamtrendite von 389% erwirtschaftet
Das Unternehmen PerkinElmer, Inc ist in mehr als 51 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Large Cap Gr AlphaDEX® ETF gewichtet Perkinelmer mit 0,91% im ETF.
Entdecke die 6 ETFs in denen PerkinElmer, Inc am höchsten gewichtet ist Insgesamt in 51 ETFs enthalten
Dir gefallen die Informationen zu Perkinelmer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Perkinelmer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Perkinelmer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Perkinelmer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
90 News & Informationen zur Perkinelmer Aktie
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.
Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by …
Worldwide Industrial Radiography Equipment Industry to 2026 – Rising Demand for Portable Radiography Equipment Presents Opportunities
/PRNewswire/ — The “Industrial Radiography Equipment Market Research Report by Application, by Region – Global Forecast to 2026 – Cumulative Impact of…
PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q2 2021 Results – Earnings Call Transcript
PerkinElmer, Inc. (NYSE:PKI) Q2 2021 Earnings Conference Call July 26, 2021, 08:00 AM ET Company Participants Steven Willoughby – VP of IR Prahlad Singh – President and CEO Jamey Mock – SVP…
$13+ Billion Worldwide Digital Forensics Industry to 2027 – Key Drivers and Challenges
/PRNewswire/ — The “Digital Forensics Market Global Forecast Impact of COVID-19, by Component, Region, End User, Company Overview, Sales Analysis” report has…
Stocks That Hit 52-Week Highs On Tuesday
This morning 85 companies set new 52-week highs.
Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet …
Hasbro, AON rise; Tencent, Fair Isaac fall
Stocks that traded heavily or had substantial price changes Monday: Hasbro, AON rise; Tencent, Fair Isaac fall
Hasbro And Carnival Lead The DIA In A Mixed Day Of Trading – SPDR Dow Jones Industrial Average ETF Trust (DIA)
U.S. indices had a mixed day of trading Monday as investors continue to weigh recent earnings and monitor COVID-19 delta variant uncertainty.
…
PerkinElmer, Inc. — Moody's affirms PerkinElmer's Baa3 senior unsecured rating; outlook changed to stable
Rating Action: Moody's affirms PerkinElmer's Baa3 senior unsecured rating; outlook changed to stableRead the full article at Moody's
PerkinElmer to pay $5.25B for antibody maker BioLegend
PerkinElmer will spend about $5.25 billion to acquire BioLegend, which makes antibodies used in gene therapy and reagents for drug discovery
PerkinElmer Buying Antibodies Maker BioLegend for $5.25 Billion
The deal is expected to boost PerkinElmer’s existing revenue growth and profit margin profile, and add to adjusted earnings a share in the first full year after the closing.
PerkinElmer (PKI) Tops Q2 Earnings and Revenue Estimates
PerkinElmer (PKI) delivered earnings and revenue surprises of 17.43% and 9.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
PerkinElmer to acquire BioLegend for ~$5.25 billion in cash and stock (NYSE:PKI)
Privately-held BioLegend is a provider of antibodies and reagents in cytometry, proteogenomics, multiplex assays, recombinant proteins, magnetic cell separation,…
PerkinElmer : Announces Financial Results for the Second Quarter of 2021
Revenue of $1.228 billion; 51% reported growth; 41% organic growth
GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83
Initiates Third Quarter and Raises Full-Year Revenue and… | July 26, 2021
PerkinElmer : to Acquire Antibody and Reagent Leader BioLegend
Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine
Leader in antibody development with highly complementary,… | July 26, 2021
Global COVID-19 antigen test market size valuation to surpass USD 8 billion by 2027
The latest business intelligence report on ‘global COVID-19 antigen test market’ provides an in-depth study of the dynamics of this industry sphere and is…
Insights On The Molecular Diagnostics Global Market To 2026 – Featuring Agilent Technologies, BioMerieux And Immucor Among Others
DUBLIN, July 23, 2021 /PRNewswire/ — The
Insights on the Molecular Diagnostics Global Market to 2026 – Featuring Agilent Technologies, bioMerieux and Immucor Among Others
/PRNewswire/ — The
Next Generation Sequencing Market Size Worth USD 20,347.45 Million by 2025 at 18.05% CAGR – Report by Market Research Future (MRFR)
Next-Generation Sequencing Market Insights and Industry Analysis by Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome…
Chiral Chemicals Market growth analysis in Diversified Chemical | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9% during the forecast…
Chiral Chemicals Market growth analysis in Diversified Chemical | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9% during the forecast…
Chiral Chemicals Market growth analysis in Diversified Chemical | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9% during the forecast…
Chiral Chemicals Market Growth Analysis In Diversified Chemical | Emerging Trends, Company Risk, And Key Executives | Technavio
NEW YORK, July 20, 2021 /PRNewswire/ — The chiral chemicals market is poised to grow by USD 5.89 billion during 2021-2025 progressing at a CAGR of almost 9%
Hedge Funds Have Never Been This Bullish On News Corp (NWS)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth
/PRNewswire/ — The “Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, Country Data (17 Countries), and…
Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth
DUBLIN, July 16, 2021 /PRNewswire/ — The 'Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, …
Worldwide Gene Expression Analysis Industry To 2026 – Key Players Include GE Healthcare, Oxford Gene Technology And Qiagen
DUBLIN, July 15, 2021 /PRNewswire/ — The “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”
Global Coronavirus Testing Kits Market Report 2021-2026: RT-PCR, Rapid Diagnostics Test, ELISA Test and Others
/PRNewswire/ — The “Global Coronavirus Testing Kits Market, By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test…
Global Animal Model Market Is Expected to Reach $2.67 Billion by 2030: Says AMR
Increase in usage of animal models in virology and infectious diseases, rise in adoption of CRISPR technology, and upsurge in likelihood of epidemic or…
Insights on the Multimodal Image Fusion Software Global Market to 2028 – by Type, Application and Geography
/PRNewswire/ — The “Multimodal Image Fusion Software Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type and Application” report has been…
Capillary Electrophoresis Market|COVID-19 Impact Analysis|Technavio
NEW YORK, July 13, 2021 /PRNewswire/ –The capillary electrophoresis market is poised to grow by USD 248.09 million during 2021-2025, progressing …
Capillary Electrophoresis Market|COVID-19 Impact Analysis|Technavio
/PRNewswire/ — The capillary electrophoresis market is poised to grow by USD 248.09 million during 2021-2025, progressing at a CAGR of 5.85% during the…
Capillary Electrophoresis Market|COVID-19 Impact Analysis|Technavio
/PRNewswire/ — The capillary electrophoresis market is poised to grow by USD 248.09 million during 2021-2025, progressing at a CAGR of 5.85% during the…
Capillary Electrophoresis Market|COVID-19 Impact Analysis|Technavio
/PRNewswire/ — The capillary electrophoresis market is poised to grow by USD 248.09 million during 2021-2025, progressing at a CAGR of 5.85% during the…
COVID-19 Antigen Test Market Size Worth $8.3 Billion By 2027: Grand View Research, Inc.
SAN FRANCISCO, July 13, 2021 /PRNewswire/ — The global COVID-19 antigen test market size is expected to reach USD 8.3 billion by 2027, according …
COVID-19 Antigen Test Market Size Worth $8.3 Billion By 2027: Grand View Research, Inc.
/PRNewswire/ — The global COVID-19 antigen test market size is expected to reach USD 8.3 billion by 2027, according to a new report by Grand View Research,…
Worldwide Next-Generation Sequencing Industry to 2026 – Key Players Include Agilent Technologies, 10x Genomics and BGI Group Among Others
/PRNewswire/ — The “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been…
Biotechnology Reagents Market: Analysis Of Key Drivers And Trends
NEW YORK, July 12, 2021 /PRNewswire/ — The biotechnology reagents market is expected to grow by USD 32.11 billion, progressing at a CAGR of 7.39% during the
Biotechnology Reagents Market: Analysis Of Key Drivers And Trends
NEW YORK, July 12, 2021 /PRNewswire/ — The biotechnology reagents market is expected to grow by USD 32.11 billion, progressing at a CAGR of 7.39% during the
Biotechnology Reagents Market: Analysis Of Key Drivers And Trends
NEW YORK, July 12, 2021 /PRNewswire/ — The biotechnology reagents market is expected to grow by USD 32.11 billion, progressing at a CAGR of 7.39% during the
The Worldwide Microplate Systems Industry is Expected to Reach $1.1+ Billion by 2026 at a CAGR of 4.8% from 2021
/PRNewswire/ — The “Microplate Systems Market by Product (Microplate Reader (Multi-mode, Single-mode), Microplate Washer, Microplate Accessories), Application…